Literature DB >> 29756208

Impact of loss-of-function mutations at the RNF43 locus on colorectal cancer development and progression.

Tsugio Eto1,2, Keisuke Miyake1,2, Katsuhiko Nosho3, Masaki Ohmuraya4, Yu Imamura5, Kota Arima2, Shinichi Kanno3, Lingfeng Fu1,2, Yuki Kiyozumi1, Daisuke Izumi1, Hidetaka Sugihara1, Yukiharu Hiyoshi1, Yuji Miyamoto1, Hiroshi Sawayama1, Masaaki Iwatsuki1, Yoshifumi Baba1, Naoya Yoshida1, Toru Furukawa6, Kimi Araki7, Hideo Baba1, Takatsugu Ishimoto1,2.   

Abstract

RNF43 mutations are frequently detected in colorectal cancer cells and lead to a loss of function of the ubiquitin E3 ligase. Here, we investigated the clinical significance of RNF43 mutations in a large Japanese cohort and the role of RNF43 at various stages of colorectal cancer development and progression. Mutation analysis of the RNF43 gene locus with pyrosequencing technology detected RNF43 hotspot mutations in one (0.88%) of 113 colorectal polyp cases and in 30 (6.45%) of 465 colorectal cancer cases. Moreover, patients with colorectal cancer harbouring mutated RNF43 experienced a higher recurrence rate than those harbouring non-mutated RNF43. In addition, the growth of RNF43 wild-type colorectal cancer cell lines was significantly increased by RNF43 silencing. We generated Rnf43 knockout mice in a C57BL/6 N background by using the CRISPR-Cas9 system. Although intestinal organoids from Rnf43 knockout mice did not show continuous growth in the absence of R-spondin, an azoxymethane/dextran sodium sulphate mouse model demonstrated that tumours were markedly larger in Rnf43 knockout mice than in wild-type mice. These findings provide evidence that Wnt signalling activation by RNF43 mutations during the tumourigenic stage enhances tumour growth and promotes a high recurrence rate in colorectal cancer patients.
Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  RNF43 mutation; Wnt signalling; colorectal cancer

Mesh:

Substances:

Year:  2018        PMID: 29756208     DOI: 10.1002/path.5098

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  16 in total

1.  Generation of focal mutations and large genomic deletions in the pancreas using inducible in vivo genome editing.

Authors:  Amrendra Mishra; Fatemeh Emamgholi; Zulrahman Erlangga; Björn Hartleben; Kristian Unger; Katharina Wolff; Ulrike Teichmann; Michael Kessel; Norman Woller; Florian Kühnel; Lukas E Dow; Michael P Manns; Arndt Vogel; Scott W Lowe; Anna Saborowski; Michael Saborowski
Journal:  Carcinogenesis       Date:  2020-05-14       Impact factor: 4.944

2.  Commonly observed RNF43 mutations retain functionality in attenuating Wnt/β-catenin signaling and unlikely confer Wnt-dependency onto colorectal cancers.

Authors:  Shan Li; Marla Lavrijsen; Aron Bakker; Marcin Magierowski; Katarzyna Magierowska; Pengyu Liu; Wenhui Wang; Maikel P Peppelenbosch; Ron Smits
Journal:  Oncogene       Date:  2020-02-26       Impact factor: 9.867

3.  RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

Authors:  Tomasz Radaszkiewicz; Michaela Nosková; Kristína Gömöryová; Olga Vondálová Blanářová; Katarzyna Anna Radaszkiewicz; Markéta Picková; Ráchel Víchová; Tomáš Gybeľ; Karol Kaiser; Lucia Demková; Lucia Kučerová; Tomáš Bárta; David Potěšil; Zbyněk Zdráhal; Karel Souček; Vítězslav Bryja
Journal:  Elife       Date:  2021-10-27       Impact factor: 8.140

Review 4.  Clone wars: From molecules to cell competition in intestinal stem cell homeostasis and disease.

Authors:  Gabriele Colozza; So-Yeon Park; Bon-Kyoung Koo
Journal:  Exp Mol Med       Date:  2022-09-18       Impact factor: 12.153

5.  Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer.

Authors:  Andreas Seeber; Francesca Battaglin; Kai Zimmer; Florian Kocher; Yasmine Baca; Joanne Xiu; Gilbert Spizzo; Veronica Novotny-Diermayr; Dietmar Rieder; Alberto Puccini; Jeff Swensen; Michelle Ellis; Richard M Goldberg; Axel Grothey; Anthony F Shields; John L Marshall; Benjamin A Weinberg; Paul E Sackstein; Kiat Hon Lim; Gek San Tan; Chadi Nabhan; W Michael Korn; Arno Amann; Zlatko Trajanoski; Martin D Berger; Emil Lou; Dominik Wolf; Heinz-Josef Lenz
Journal:  Clin Cancer Res       Date:  2022-05-02       Impact factor: 13.801

Review 6.  Mutations and mechanisms of WNT pathway tumour suppressors in cancer.

Authors:  Jeroen M Bugter; Nicola Fenderico; Madelon M Maurice
Journal:  Nat Rev Cancer       Date:  2020-10-23       Impact factor: 60.716

Review 7.  Casein Kinase 1α as a Regulator of Wnt-Driven Cancer.

Authors:  Chen Shen; Anmada Nayak; Ricardo A Melendez; Daniel T Wynn; Joshua Jackson; Ethan Lee; Yashi Ahmed; David J Robbins
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 6.208

8.  RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer.

Authors:  Akio Matsumoto; Yoshifumi Shimada; Mae Nakano; Hidehito Oyanagi; Yosuke Tajima; Masato Nakano; Hitoshi Kameyama; Yuki Hirose; Hiroshi Ichikawa; Masayuki Nagahashi; Hitoshi Nogami; Satoshi Maruyama; Yasumasa Takii; Yiwei Ling; Shujiro Okuda; Toshifumi Wakai
Journal:  Oncol Rep       Date:  2020-03-23       Impact factor: 3.906

Review 9.  Actionable Potentials of Less Frequently Mutated Genes in Colorectal Cancer and Their Roles in Precision Medicine.

Authors:  Ryia Illani Mohd Yunos; Nurul Syakima Ab Mutalib; Francis Yew Fu Tieng; Nadiah Abu; Rahman Jamal
Journal:  Biomolecules       Date:  2020-03-20

Review 10.  Current challenges in the implementation of precision oncology for the management of metastatic colorectal cancer.

Authors:  Sun Young Kim; Tae Won Kim
Journal:  ESMO Open       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.